A new player in the treatment of HER2-positive tumours. | Lancet Oncol;20(6): 748-750, 2019 06. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Search Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

A new player in the treatment of HER2-positive tumours.

Giannone, Gaia; Montemurro, Filippo.

Affiliation

Giannone G; Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo 10060, Italy.
Montemurro F; Multidisciplinary Outpatient Oncology Clinic, Candiolo Cancer Institute, FPO-IRCCS, Candiolo 10060, Italy. Electronic address: filippo.montemurro@ircc.it.

Lancet Oncol ; 20(6): 748-750, 2019 06.

Article in En | MEDLINE | ID: mdl-31047805

Subject(s)

Breast Neoplasms; Ado-Trastuzumab Emtansine; Antibodies, Monoclonal, Humanized; Camptothecin/analogs & derivatives; Humans; Immunoconjugates; Receptor, ErbB-2; Trastuzumab

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Humans Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2019 Type: Article Affiliation country: Italy

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Humans Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2019 Type: Article Affiliation country: Italy